Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming
- PMID: 31209174
- PMCID: PMC6697398
- DOI: 10.1523/JNEUROSCI.0966-19.2019
Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming
Abstract
In addition to analgesia, opioids produce opioid-induced hyperalgesia (OIH) and neuroplasticity characterized by prolongation of inflammatory-mediator-induced hyperalgesia (hyperalgesic priming). We evaluated the hypothesis that hyperalgesia and priming induced by opioids are mediated by similar nociceptor mechanisms. In male rats, we first evaluated the role of nociceptor Toll-like receptor 4 (TLR4) in OIH and priming induced by systemic low-dose morphine (LDM, 0.03 mg/kg). Intrathecal oligodeoxynucleotide antisense to TLR4 mRNA (TLR4 AS-ODN) prevented OIH and prolongation of prostaglandin E2 hyperalgesia (priming) induced by LDM. In contrast, high-dose morphine (HDM, 3 mg/kg) increased nociceptive threshold (analgesia) and induced priming, neither of which was attenuated by TLR4 AS-ODN. Protein kinase C ε (PKCε) AS-ODN also prevented LDM-induced hyperalgesia and priming, whereas analgesia and priming induced by HDM were unaffected. Treatment with isolectin B4 (IB4)-saporin or SSP-saporin (which deplete IB4+ and peptidergic nociceptors, respectively), or their combination, prevented systemic LDM-induced hyperalgesia, but not priming. HDM-induced priming, but not analgesia, was markedly attenuated in both saporin-treated groups. In conclusion, whereas OIH and priming induced by LDM share receptor and second messenger mechanisms in common, action at TLR4 and signaling via PKCε, HDM-induced analgesia, and priming are neither TLR4 nor PKCε dependent. OIH produced by LDM is mediated by both IB4+ and peptidergic nociceptors, whereas priming is not dependent on the same population. In contrast, priming induced by HDM is mediated by both IB4+ and peptidergic nociceptors. Implications for the use of low-dose opioids combined with nonopioid analgesics and in the treatment of opioid use disorder are discussed.SIGNIFICANCE STATEMENT Opioid-induced hyperalgesia (OIH) and priming are common side effects of opioid agonists such as morphine, which acts at μ-opioid receptors. We demonstrate that OIH and priming induced by systemic low-dose morphine (LDM) share action at Toll-like receptor 4 (TLR4) and signaling via protein kinase C ε (PKCε) in common, whereas systemic high-dose morphine (HDM)-induced analgesia and priming are neither TLR4 nor PKCε dependent. OIH produced by systemic LDM is mediated by isolectin B4-positive (IB4+) and peptidergic nociceptors, whereas priming is dependent on a different class of nociceptors. Priming induced by systemic HDM is, however, mediated by both IB4+ and peptidergic nociceptors. Our findings may provide useful information for the use of low-dose opioids combined with nonopioid analgesics to treat pain and opioid use disorders.
Keywords: hyperalgesic priming; morphine; opioid-induced hyperalgesia (OIH); protein kinase epsilon (PKCε); toll-like receptor 4 (TLR4).
Copyright © 2019 the authors.
Figures






Similar articles
-
In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.J Neurosci. 2019 Sep 4;39(36):7061-7073. doi: 10.1523/JNEUROSCI.1191-19.2019. Epub 2019 Jul 12. J Neurosci. 2019. PMID: 31300521 Free PMC article.
-
Opioid-Induced Hyperalgesic Priming in Single Nociceptors.J Neurosci. 2021 Jan 6;41(1):31-46. doi: 10.1523/JNEUROSCI.2160-20.2020. Epub 2020 Nov 17. J Neurosci. 2021. PMID: 33203743 Free PMC article.
-
Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.Neuroscience. 2019 Feb 1;398:64-75. doi: 10.1016/j.neuroscience.2018.11.051. Epub 2018 Dec 7. Neuroscience. 2019. PMID: 30529265 Free PMC article.
-
Roles of Proton-Sensing Receptors in the Transition from Acute to Chronic Pain.J Dent Res. 2016 Feb;95(2):135-42. doi: 10.1177/0022034515618382. Epub 2015 Nov 23. J Dent Res. 2016. PMID: 26597969 Review.
-
Opioid-induced hyperalgesia: Cellular and molecular mechanisms.Neuroscience. 2016 Dec 3;338:160-182. doi: 10.1016/j.neuroscience.2016.06.029. Epub 2016 Jun 23. Neuroscience. 2016. PMID: 27346146 Review.
Cited by
-
The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance.Front Pharmacol. 2023 Dec 15;14:1297931. doi: 10.3389/fphar.2023.1297931. eCollection 2023. Front Pharmacol. 2023. PMID: 38161698 Free PMC article. Review.
-
Sexually Dimorphic Role of Toll-like Receptor 4 (TLR4) in High Molecular Weight Hyaluronan (HMWH)-induced Anti-hyperalgesia.J Pain. 2021 Oct;22(10):1273-1282. doi: 10.1016/j.jpain.2021.03.152. Epub 2021 Apr 20. J Pain. 2021. PMID: 33892155 Free PMC article.
-
Impact of SARS-CoV-2 Infection on the Epidemiology of Chronic Pain and Long-Term Disability: Prepare for the Next Perfect Storm.Front Pain Res (Lausanne). 2020 Dec 15;1:616284. doi: 10.3389/fpain.2020.616284. eCollection 2020. Front Pain Res (Lausanne). 2020. PMID: 35295694 Free PMC article. No abstract available.
-
Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.Brain. 2024 Mar 1;147(3):1025-1042. doi: 10.1093/brain/awad339. Brain. 2024. PMID: 37787114 Free PMC article.
-
Isolectin B4 (IB4)-conjugated streptavidin for the selective knockdown of proteins in IB4-positive (+) nociceptors.Mol Pain. 2024 Jan-Dec;20:17448069241230419. doi: 10.1177/17448069241230419. Mol Pain. 2024. PMID: 38246917 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials